1997
DOI: 10.1097/01376517-199706000-00007
|View full text |Cite
|
Sign up to set email alerts
|

Serotonergic Receptors as Targets for Pharmacotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2005
2005
2021
2021

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 0 publications
0
5
0
Order By: Relevance
“…Expression of transporters in chick is asymmetric, and thus may be expected to differentially regulate the availability of intracellular and extracellular 5-HT on the left versus right sides of Hensen's node. Since storage of serotonin in vesicles prevents catabolism by MAO prior to synaptic release [Kirk et al, 1997], VMAT activity may interact with the rightsided MAO expression [Fukumoto et al, 2005] to precisely control 5-HT levels. The function of SERT can increase cytoplasmic 5-HT but also reduce the availability of serotonin to neighboring cells.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Expression of transporters in chick is asymmetric, and thus may be expected to differentially regulate the availability of intracellular and extracellular 5-HT on the left versus right sides of Hensen's node. Since storage of serotonin in vesicles prevents catabolism by MAO prior to synaptic release [Kirk et al, 1997], VMAT activity may interact with the rightsided MAO expression [Fukumoto et al, 2005] to precisely control 5-HT levels. The function of SERT can increase cytoplasmic 5-HT but also reduce the availability of serotonin to neighboring cells.…”
Section: Discussionmentioning
confidence: 99%
“…To avoid degradation and provide for vesicular release, 5-HT is transported into vesicles through the action of the vesicular monoamine transporter (VMAT) [Kirk et al, 1997]. VMAT (VMAT2 in neurons, and VMAT1 in other tissues) uses proton gradients generated by the V-ATPase [Harvey, 1992] to drive transport exchanging two protons in the lumen of the vesicle for one monoamine in the cytoplasm [Knoth, 1981a, b;Kanner, 1987;Edwards, 1992].…”
Section: Introductionmentioning
confidence: 99%
“…The serotonin pathway [Cooper et al, 1996] includes enzymes which synthesize 5-HT from the essential amino acid L -tryptophan, membrane receptors, which transduce the serotonin signal into different downstream cellular events (5-HT 1-7 ), and a system for enzymatic degradation of 5-HT via monoamine oxidase (MAO) [Gershon et al, 1990;Kirk et al, 1997]. Many cell types also possess a system of storage and release of 5-HT by vesicles, and a plasma membrane transporter (SERT) that imports extracellular 5-HT into the cytoplasm.…”
Section: Introductionmentioning
confidence: 99%
“…Serotonin is a monoamine synthesized intracellularly from L-tryptophan, released, and later degraded via monoamine oxidase action ( Kirk et al, 1997 ; Sahu et al, 2018 ). The serotonin signaling is transduced to subcellular events by specific membrane receptors of different classes.…”
Section: Serotonin Signaling Components Are Present In Craniofacial Tissuesmentioning
confidence: 99%